Previous 10 | Next 10 |
home / stock / zldaf / zldaf news
Both Senate seats went to Democrats and this allows for a blue agenda with cannabis legalization being one of the top priorities. Arizona's legalization of recreational cannabis is already being geared up for with companies retooling in preparation. The industry will see continued...
2020 saw increases of 80% in Canada and expectations are for that to double next year. California will lead revenue growth rates as the state continues to ramp up the industry. Washington and Colorado are starting to see overall growth rates slow modestly, excepting pandemic-induc...
Several mergers have been announced over the past few days and this has driven cannabis stocks upwards. A newer industry is still seeing tremendous growth rates in QoQ revenues. Keeping an eye on the fastest growing revenue stocks may be key to increasing profits in investments. ...
Zelira Therapeutics Expands HOPE™ Distribution in the US Through Licensing Agreement with Alternative Solutions in Washington DC PHILADELPHIA , Dec. 15, 2020 /PRNewswire/ -- Zelira Therapeutics Ltd (ASX:ZLD, OTCQB:ZLDAF), a global leader in the development of ...
Autism is a developmental disorder characterized by communication and behavioral difficulties from minor to extremely severe. There is no medical cure for autism and much remains mysterious about the condition. There is no blood test or similarly straightforward means of diagnosis, ...
PHILADELPHIA , July 22, 2020 /PRNewswire/ -- Zelira Therapeutics Ltd ( ASX: ZLD) (OTCQB: ZLDAF ), a global leader in the development of clinically validated cannabis medicines, is pleased to announce it has entered into a binding agreement with US-based Cardiovascular Solutions...
The cannabis industry continued to feel pressure from COVID-19 this week, with companies in the US and Canada beginning to parse out whether they will be able to access government benefits. Meanwhile, Ontario reversed a decision made last week, allowing brick-and-mortar cannabis ...
PHILADELPHIA , April 7, 2020 /PRNewswire/ -- Zelira Therapeutics Ltd ( ASX: ZLD, OTCQB: ZLDAF ), a global leader in the development of clinically validated cannabis medicines based in both Perth, Australia and Philadelphia , is pleased to announce it has received the final repor...
PERTH, Australia , Feb. 18, 2020 /PRNewswire/ -- Zelira Therapeutics Ltd ( ASX: ZLD, OTCQB: ZLDAF ), a global leader in the development of clinically validated cannabis medicines, today announced positive Phase 1b /2a results confirming that ZLT-101 therapy achieved the primar...
PERTH, Australia , Jan. 28, 2020 /PRNewswire/ -- Zelira Therapeutics Limited (ASX: ZLD, OTCQB: ZLDAF) is pleased to announce a collaboration with the Parkinson's Foundation, one of the United States of America's leading communities for people living with Parkinson's diseas...
News, Short Squeeze, Breakout and More Instantly...
Zelda Therapeutics Ltd Company Name:
ZLDAF Stock Symbol:
OTCMKTS Market:
Zelda Therapeutics Ltd Website:
Zelira Therapeutics Ltd (ASX: ZLD) (OTCQB: ZLDAF) said that it has funding to conduct mid-to-late-stage FDA trials for its cannabinoid-based drug to treat autism spectrum disorder (ASD). The company received $8.6 million in funding from U.S.-based investment firm Cantheon Capital LLC to con...
Zelira Therapeutics Launches ZYRAYDI™ B2B Technology to Create Pharma-grade Cannabis Capsules & Tablets for Global Markets Zelira Therapeutics Launches ZYRAYDI™ B2B Technology to Create Pharma-grade Cannabis Capsules & Tablets for Global Markets PR News...
Zelira Therapeutics Ltd (ASX: ZLD,OTC-QB: ZLDAF ), recieved formal approval from German regulatory authority BfArM to launch in the German medical cannabis market for its new insomnia medication Zenivol. Zenivol is the first clinically validated , pharmaceutic...